Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from CellSource Co., Ltd. ( (JP:4880) ).
CellSource Co., Ltd. announced a resolution to amend its Articles of Incorporation to reflect its business expansion and diversification. The proposed amendments, to be discussed at the upcoming shareholders’ meeting, include adding new business purposes such as fitness-related services, consulting, and real estate management, indicating a strategic shift to broaden its market reach and operational capabilities.
The most recent analyst rating on (JP:4880) stock is a Hold with a Yen547.00 price target. To see the full list of analyst forecasts on CellSource Co., Ltd. stock, see the JP:4880 Stock Forecast page.
More about CellSource Co., Ltd.
CellSource Co., Ltd. operates in the pharmaceutical and health-related industry, focusing on the design, development, manufacture, and sale of pharmaceuticals, quasi-pharmaceuticals, regenerative medical products, cosmetics, health food, medical devices, and related products. The company is expanding its business scope to include fitness-related products and services, consulting, and real estate management.
Average Trading Volume: 80,833
Technical Sentiment Signal: Sell
Current Market Cap: Yen8.62B
See more insights into 4880 stock on TipRanks’ Stock Analysis page.